Keep up to date with every new upload!

Join free & follow HealthProfessionalRadio
FDA Approval of KEYTRUDA for Treatment of Gastric Cancer

FDA Approval of KEYTRUDA for Treatment of Gastric Cancer

Dr. Charles S. Fuchs discusses the recent FDA approval of KEYTRUDA (pembrolizumab) for patients with advanced gastric cancer that have received 2 or more lines of chemotherapy, and what this means for patients, doctors, and caregivers.

Comments